Projects per year
Personal profile
Research Interests
The researcher's five main lines of investigation are:
- Mucosal immunology.
- Tumor microenvironment.
- Colorectal cancer.
- Inflammatory bowel disease.
- Functional digestive disorders.
- Mucosal immunology.
- Tumor microenvironment.
- Colorectal cancer.
- Inflammatory bowel disease.
- Functional digestive disorders.
Personal resumeDr. Landskron is a Medical Technologist in Clinical Laboratory, Hematology, and Blood Bank from the University of Antofagasta, and holds a Ph.D. in Biomedical Sciences from the University of Chile. Currently, she is a Research Academic and Assistant Professor at the Center for Advanced Biomedical Research (CIBMED) at the School of Medicine, Finis Terrae University since 2021. Her research line is basic-clinical in nature, focusing on mucosal immunology and its application to various gastrointestinal pathologies such as irritable bowel syndrome, inflammatory bowel diseases, and colorectal cancer. She is currently studying the role of the antitumor immune response and evasion mechanisms in the development and progression of colon cancer in the presence of chronic inflammatory conditions, such as obesity, and how they influence disease course and tumor microenvironment remodeling.
Fingerprint
Dive into the research topics where Glauben Landskron Ramos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Projects
- 1 Finished
-
FONDECYT de Iniciación 2023-Role of the m6A-demethylase FTO in tumor-infiltrating T cell-mediated immune evasion of colorectal cancer.
Landskron Ramos, G. (PI)
1/01/23 → 1/01/25
Project: Research › Applied research
-
Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study
von Muhlenbrock, C., Landskron, G. & Madrid, A. M., 1 Jan 2025, In: Revista de gastroenterología de México. 90, 1, p. 54-62 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Corrigendum: The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD (Front. Immunol., (2022), 13, 1028953, 10.3389/fimmu.2022.1028953)
Astorga, J., Gasaly, N., Dubois-Camacho, K., De la Fuente, M., Landskron, G., Faber, K. N., Urra, F. A. & Hermoso, M. A., 1 Jan 2024, In: Frontiers in Immunology. 15, p. 1384162 1384162.Research output: Contribution to journal › Article › peer-review
Open Access -
Exploring the lutein therapeutic potential in steatotic liver disease: mechanistic insights and future directions
Balboa, E., Saud, F., Parra-Ruiz, C., de la Fuente, M., Landskron, G. & Zanlungo, S., 1 Jan 2024, In: Frontiers in Pharmacology. 15, 1406784.Research output: Contribution to journal › Review article › peer-review
Open Access -
Intragastric administration of short chain fatty acids greatly reduces voluntary ethanol intake in rats
Quintanilla, M. E., Santapau, D., Diaz, E., Valenzuela Martinez, I., Medina, N., Landskron, G., Dominguez, A., Morales, P., Ramírez, D., Hermoso, M., Olivares, B., Berríos-Cárcamo, P., Ezquer, M., Herrera-Marschitz, M., Israel, Y. & Ezquer, F., 1 Dec 2024, In: Scientific Reports. 14, 1, 29260.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Pannexin-1 expression in tumor cells correlates with colon cancer progression and survival
Fierro-Arenas, A., Landskron, G., Camhi-Vainroj, I., Basterrechea, B., Parada-Venegas, D., Lobos-González, L., Dubois-Camacho, K., Araneda, C., Romero, C., Domínguez, A., Vásquez, G., López-K, F., Alvarez, K., González, C. M., Hager Ribeiro, C., Balboa, E., Eugenin, E., Hermoso, M. A. & De la Fuente López, M., 15 Aug 2024, In: Life Sciences. 351, 122851.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
Activities
- 2 Oral presentation
-
Científicos de Laboratorio: Donde la curiosidadencuentra soluciones
Landskron Ramos, G. (Speaker)
29 Aug 2024Activity: Talk or presentation › Oral presentation
-
Participacion de la desmetilasa FTO en procesos mesenquimales y cancer stem cells en cancer colorectal
Landskron Ramos, G. (Speaker)
2021Activity: Talk or presentation › Oral presentation